STO signs with India’s HLL to supply key medicines
STO stated that the country has experienced persistent difficulties in obtaining essential medicines, impacting patient care.
Top Stories
-
LGA spending exceeds approved annual budget by MVR 13 million
-
Solih: MDP won't support Ras Malé project without disclosure
-
Nasheed says Maldives foreign policy should prioritise India
-
MDP proposes chairperson as party’s highest-ranking leader
-
MDP forum to seek funding for 75 council projects worth $306m
In a move aimed at resolving longstanding shortages of essential medicines, State Trading Organisation (STO) of Maldives has signed an agreement with HLL Lifecare, a public sector company under India’s Ministry of Health and Family Welfare.
The agreement will ensure consistent and affordable access to critical drugs across Maldives, addressing a major issue in the nation’s healthcare supply chain.
STO stated that the country has experienced persistent difficulties in obtaining essential medicines, impacting patient care.
“This partnership is a direct and permanent solution,” STO announced, adding that all imported medicines will meet WHO standards and comply with Maldivian regulations.
The medicines will be supplied under India’s Pradhan Mantri Bharatiya Janaushadhu Pariyojana (PMBJP), also known as the Janaushadhu scheme, which is designed to provide affordable generic drugs.
HLL, a key player during the COVID-19 pandemic, had previously supported STO by delivering vital medications on time, proving its reliability. The current agreement builds on that successful cooperation.
“With this partnership, Maldives is now linked to one of the world’s largest pharmaceutical supply chains,” STO said.
Related
Related
Nasheed says Maldives foreign policy should prioritise India
Maldives gains access to $500M India's Exim Bank credit facility
'$50M India payment not from BML deposits, funded from SDF'